Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-31 @ 3:06 AM
Study NCT ID:
NCT04670003
Status:
COMPLETED
Last Update Posted:
2021-04-08
First Post:
2020-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D000086382', 'term': 'COVID-19'}], 'ancestors': [{'id': 'D011024', 'term': 'Pneumonia, Viral'}, {'id': 'D011014', 'term': 'Pneumonia'}, {'id': 'D012141', 'term': 'Respiratory Tract Infections'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D014777', 'term': 'Virus Diseases'}, {'id': 'D018352', 'term': 'Coronavirus Infections'}, {'id': 'D003333', 'term': 'Coronaviridae Infections'}, {'id': 'D030341', 'term': 'Nidovirales Infections'}, {'id': 'D012327', 'term': 'RNA Virus Infections'}, {'id': 'D008171', 'term': 'Lung Diseases'}, {'id': 'D012140', 'term': 'Respiratory Tract Diseases'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'PROSPECTIVE', 'observationalModel': 'COHORT'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 4975}, 'targetDuration': '3 Months', 'patientRegistry': True}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2021-01-02', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-12', 'completionDateStruct': {'date': '2021-03-30', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2021-04-06', 'studyFirstSubmitDate': '2020-12-14', 'studyFirstSubmitQcDate': '2020-12-15', 'lastUpdatePostDateStruct': {'date': '2021-04-08', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2020-12-17', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2021-03-30', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Description of the methods of contamination of patients', 'timeFrame': '2 months', 'description': 'Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)'}], 'secondaryOutcomes': [{'measure': 'Evaluation in time of the spread of the virus during the 2nd epidemic wave.', 'timeFrame': '2 months', 'description': 'Data and symptomes collected by the web applications self-questionnaire (patient reported outcome)'}, {'measure': 'Evaluation in space of the spread of the virus during the 2nd epidemic wave.', 'timeFrame': '2 months', 'description': 'Data and symptomes collected by the web applications self-questionnaire according to ZIP code (patient reported outcome)'}]}, 'oversightModule': {'oversightHasDmc': False, 'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'conditions': ['Covid19']}, 'referencesModule': {'references': [{'pmid': '33878018', 'type': 'DERIVED', 'citation': 'Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study. J Med Internet Res. 2021 May 4;23(5):e26932. doi: 10.2196/26932.'}]}, 'descriptionModule': {'briefSummary': 'A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases.\n\nViral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'All users of the application contaminated with COVID 19 who have not objected to the use of their data', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion criteria:\n\n* users of the application\n* not having objected to the use of their data\n\nExclusion criteria:\n\n\\- user who does not have a complete questionnaire'}, 'identificationModule': {'nctId': 'NCT04670003', 'acronym': 'SourceCOVID', 'briefTitle': 'Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application', 'organization': {'class': 'OTHER', 'fullName': 'Weprom'}, 'officialTitle': 'Spread Analysis of COVID-19 Outbreak in France by Self-assessment Web-application: an Observational Study', 'orgStudyIdInfo': {'id': 'WP-2020-05'}}, 'armsInterventionsModule': {'armGroups': [{'label': 'users', 'description': 'users of web-application', 'interventionNames': ['Other: users']}], 'interventions': [{'name': 'users', 'type': 'OTHER', 'description': 'Data of users of the web-application', 'armGroupLabels': ['users']}]}, 'contactsLocationsModule': {'locations': [{'zip': '72000', 'city': 'Le Mans', 'country': 'France', 'facility': 'Institut Interrégional de Cancérologie', 'geoPoint': {'lat': 48.0021, 'lon': 0.20251}}], 'overallOfficials': [{'name': 'Fabrice DENIS, MD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Institut Interrégional de Cancerologie et Kelindi'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Weprom', 'class': 'OTHER'}, 'collaborators': [{'name': 'Kelindi', 'class': 'INDUSTRY'}], 'responsibleParty': {'type': 'SPONSOR'}}}}